Recent Advances in Vitamin D3 Intervention to Eradicate Helicobacter pylori Infection
Peng-Fei Ma,Lin Zhuo,Li-Ping Yuan,Xiao-Hui Qi
DOI: https://doi.org/10.2147/jmdh.s454605
2024-02-27
Journal of Multidisciplinary Healthcare
Abstract:Peng-Fei Ma, 1, &ast Lin Zhuo, 1, &ast Li-Ping Yuan, 2 Xiao-Hui Qi 3 1 Department of Gastroenterology, Children's Hospital of Fudan University at Anhui (Anhui Provincial Children's Hospital), Hefei, Anhui, People's Republic of China; 2 Department of Pediatrics, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, People's Republic of China; 3 Department of Pediatrics, Children's Hospital of Fudan University at Anhui (Anhui Provincial Children's Hospital), Hefei, Anhui, People's Republic of China &astThese authors contributed equally to this work Correspondence: Xiao-Hui Qi, Department of Pediatrics, Children's Hospital of Fudan University at Anhui (Anhui Provincial Children's Hospital), Hefei, Anhui, People's Republic of China, Email Helicobacter pylori (HP) infections affect approximately one-third of children worldwide. In China, the incidence of HP infection in children ranges from approximately 30% to 60%. In addition to damaging the gastrointestinal tract mucosa, HP infection in children can negatively affect their growth and development, hematology, respiratory and hepatobiliary system, skin, nutritional metabolism, and autoimmune system. However, the rate of HP eradication also fell considerably from the previous rate due to the presence of drug-resistant HP strains and the limited types of antibiotics that can be used in young patients. Vitamin D3 (VitD3) is a steroid hormone that can reduce inflammation in the stomach mucosa induced by HP and can alleviate and eradicate HP through a variety of pathways and mechanisms, including immune regulation and the stimulation of antimicrobial peptide (AMP) secretion and Ca 2+ influx, to reestablish lysosomal acidification; thus, these results provide new strategies and ideas for the eradication of drug-resistant HP strains. Keywords: vitamin D3, Helicobacter pylori , immune response, AMPs, Ca 2+ channels Helicobacter pylori (HP) is a helical, microaerobic bacterium that colonizes the epithelium and lamina propria of the gastric mucosa. HP is the only microorganism known to survive in the human stomach, and HP survives by producing ammonia from urea to neutralize gastric acid. As a dependent risk factor for gastric and duodenal erosions, as well as for peptic ulcers, 1 HP is thought to induce chronic inflammation, which is characterized by lymphoplasmacytic infiltration, or acute inflammatory responses, which are characterized by neutrophil infiltration. 2 The prevalence of HP infection varies between regions of the world, although it affects roughly one-third of children worldwide. 3 The incidence of HP infection in children varies significantly by area in China, with infection rates ranging from approximately 30% to 60%. 4,5 Ren 4 and Yuan 6 discovered that the prevalence of HP infection increased with age while investigating the epidemiology of HP infection in children in China and worldwide. However, the rate of HP eradication also fell considerably from the previous rate due to the presence of drug-resistant HP strains and the limited types of antibiotics available for use in young patients. In addition to causing damage to the gastrointestinal tract mucosa, HP infection in children can negatively affect growth and development, hematology, respiratory and hepatobiliary health, skin, nutritional metabolism, and the autoimmune system. 7 Recent research has revealed a link between vitamin D3 (VitD3) deficiency and HP infection. 8–10 1.25-dihydroxyvitamin D3 [1,25(OH)2D3] is a steroid hormone derived from vitamin D. 1.25(OH)2D3 is the predominant metabolite used to determine vitamin D levels in the body, and it is derived from both dietary vitamin D (D2) and cholecalciferol (D3) through photochemical interactions with sunshine or ultraviolet light, the latter of which is its principal source. Vitamin D is converted to 25-hydroxyvitamin D3 [25(OH)D3] and 1.25-(OH)2D3 by the enzymes 25-hydroxylase in the microsomes of hepatocytes and 1-a hydroxylase in the mitochondria of proximal renal tubular epithelial cells. In 2006, Kawaura showed that regular usage of an analog of vitamin D3 called 1 alpha-hydroxyvitamin D3 decreased the incidence of Helicobacter pylori infection. 10 El Shahawy 9 reported that patients with HP infection who were vitamin D deficient had lower rates of successful eradication. Supplemental vitamin intake substantially impacts HP infection, either by directly modifying the host's inflammatory pathways or by subtly enhancing the host's immune response. It has been reported that HP infection in adults increases the number of CD4+ T cells and induces activ -Abstract Truncated-
health care sciences & services